SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALARIA CHALLENGE IN HEALTHY MALARIA-NAIVE VOLUNTEERS

SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALARIA CHALLENGE IN HEALTHY MALARIA-NAIVE VOLUNTEERS

Bibliografske podrobnosti
Main Authors:	Duncan, C, Sheehy, S, Ewer, K, Douglas, A, Halstead, F, Edwards, N, Collins, K, Lillie, P, Poulton, I, Hunt-Cooke, A, Lawrie, A, Draper, S, Gilbert, S, Fay, M, Miura, K, Long, C, Wu, Y, Hill, A, Ellis, R
Format:	Conference item
Izdano:	2010

Podobne knjige/članki

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.
od: Duncan, C, et al.
Izdano: (2011)

Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria.
od: Ruth D Ellis, et al.
Izdano: (2012-01-01)

Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults.
od: Ruth D Ellis, et al.
Izdano: (2010-01-01)

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection
od: Elias, S, et al.
Izdano: (2014)

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
od: Elias, S, et al.
Izdano: (2013)

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans
od: Sheehy, S, et al.
Izdano: (2012)

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
od: Sheehy, S, et al.
Izdano: (2012)

CLINICAL EVALUATION OF NEW VIRAL VECTORED VACCINES TARGETING THE PLASMODIUM FALCIPARUM BLOOD-STAGE ANTIGENS; MSP1 AND AMA1
od: Sheehy, S, et al.
Izdano: (2011)

Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines.
od: Sheehy, S, et al.
Izdano: (2013)

Demonstration of the blood-stage controlled human malaria infection model to assess efficacy of the Plasmodium falciparum AMA1 vaccine FMP2.1/AS01
od: Payne, R, et al.
Izdano: (2016)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
od: Sheehy, S, et al.
Izdano: (2012)

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
od: Hodgson, S, et al.
Izdano: (2014)

Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children.
od: Alassane Dicko, et al.
Izdano: (2008-02-01)

Blood-stage malaria vaccines - recent progress and future challenges.
od: Goodman, A, et al.
Izdano: (2010)

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure
od: Biswas, S, et al.
Izdano: (2014)

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
od: Elias, S, et al.
Izdano: (2014)

Controlled human blood stage malaria infection: current status and potential applications.
od: Duncan, C, et al.
Izdano: (2012)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
od: Draper, S, et al.
Izdano: (2005)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
od: Ewer, K, et al.
Izdano: (2015)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
od: Sheehy, S, et al.
Izdano: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
od: Sheehy, S, et al.
Izdano: (2011)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
od: Forbes, E, et al.
Izdano: (2011)

Developing novel blood-stage malaria vaccines
od: Douglas, AD
Izdano: (2015)

An essential malaria protein defines the architecture of blood-stage and transmission-stage parasites
od: Sabrina Absalon, et al.
Izdano: (2016-04-01)

Role of distinct DC subsets in blood-stage malaria immunity
od: Tamara A. Nair
Izdano: (2012)

Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine
od: Guindo Aldiouma, et al.
Izdano: (2011-01-01)

Longevity of the immune response and memory to blood-stage malaria infection.
od: Achtman, A, et al.
Izdano: (2005)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
od: Pukrittayakamee, S, et al.
Izdano: (1994)

Prime and target immunization protects against liver-stage malaria in mice
od: Gola, A, et al.
Izdano: (2018)

New antigens for a multicomponent blood-stage malaria vaccine.
od: Osier, F, et al.
Izdano: (2014)

Deconvoluting heme biosynthesis to target blood-stage malaria parasites
od: Paul A Sigala, et al.
Izdano: (2015-07-01)

Mouse Models for Unravelling Immunology of Blood Stage Malaria
od: Adesola C. Olatunde, et al.
Izdano: (2022-09-01)

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
od: Douglas, A, et al.
Izdano: (2011)

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
od: Minassian, AM, et al.
Izdano: (2021)

Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria.
od: Silamut, K, et al.
Izdano: (1993)

Malaria blood stage infection suppresses liver stage infection via host-induced interferons but not hepcidin
od: Hardik Patel, et al.
Izdano: (2024-03-01)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
od: Goodman, A, et al.
Izdano: (2009)

Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
od: Elizabeth M Parzych, et al.
Izdano: (2020-01-01)

Biophysical Tools and Concepts Enable Understanding of Asexual Blood Stage Malaria
od: Viola Introini, et al.
Izdano: (2022-05-01)

Functional comparison of blood-stage plasmodium falciparum malaria vaccine candidate antigens
od: Illingworth, JJ, et al.
Izdano: (2019)